No Data
No Data
No Data
No Data
No Data
Wolf Popper LLP Continues Its Investigation on Behalf of Investors in Harmony Biosciences Holdings, Inc.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is continuing to investigate potential securities fraud claims on behalf of purchasers of Harmony Biosciences Holdings, Inc. ("Harmony") common stock
GlobeNewswireApr 25 07:00 ET
HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024
PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report first quarter 2024 financial results on Tuesday, April 30,
PR NewswireApr 16 08:05 ET
Piper Sandler Remains a Buy on Harmony Biosciences Holdings (HRMY)
TipRanksApr 12 08:30 ET
Harmony Inks Licensing Deal for Sleep Disorder Therapy
Seeking AlphaApr 11 12:36 ET
Harmony Biosciences Holdings (HRMY) Gets a Sell From Goldman Sachs
TipRanksApr 11 10:45 ET
Harmony Biosciences Secures Rights to Narcolepsy Treatment
InvestingApr 11 10:20 ET
kumarpentakota : where did you get this data
Joy Boy Myth : wonderful, Meltyy... thank you...
Trytosaveabit : Thank you for sharing! GL
102415025 : Wait for the good news later
73103485 : thank you you are super
No Data
No Data